Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Insulin Aspart versus Insulin Lispro

Subjects will be randomly assigned to insulin aspart versus insulin lispro via random number generation. Half of the patients will begin with insulin aspart, and then will be crossed over to insulin lispro. The insulin sequence will be reversed for the other half of the patients.

DRUG

Insulin Lispro versus Insulin Aspart

Subjects will be randomly assigned to insulin lispro versus insulin aspart via random number generation. Half of the patients will begin with insulin lispro, and then will be crossed over to insulin aspart. The insulin sequence will be reversed for the other half of the patients.

Trial Locations (1)

02215

Joslin Diabetes Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Joslin Diabetes Center

OTHER